220 related articles for article (PubMed ID: 29146125)
1. All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis.
Wehner MR; Cidre Serrano W; Nosrati A; Schoen PM; Chren MM; Boscardin J; Linos E
J Am Acad Dermatol; 2018 Apr; 78(4):663-672.e3. PubMed ID: 29146125
[TBL] [Abstract][Full Text] [Related]
2. Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.
Rees JR; Zens MS; Celaya MO; Riddle BL; Karagas MR; Peacock JL
Int J Cancer; 2015 Aug; 137(4):878-884. PubMed ID: 25598534
[TBL] [Abstract][Full Text] [Related]
3. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.
Flohil SC; van der Leest RJ; Arends LR; de Vries E; Nijsten T
Eur J Cancer; 2013 Jul; 49(10):2365-75. PubMed ID: 23608733
[TBL] [Abstract][Full Text] [Related]
4. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
[TBL] [Abstract][Full Text] [Related]
5. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
6. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Basal cell and squamous cell carcinoma of the skin in Finland. Site distribution and patient survival.
Karjalainen S; Salo H; Teppo L
Int J Dermatol; 1989 Sep; 28(7):445-50. PubMed ID: 2777443
[TBL] [Abstract][Full Text] [Related]
9. Mortality in Danish patients with nonmelanoma skin cancer, 1978-2001.
Jensen AØ; Bautz A; Olesen AB; Karagas MR; Sørensen HT; Friis S
Br J Dermatol; 2008 Aug; 159(2):419-25. PubMed ID: 18616784
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.
Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416
[No Abstract] [Full Text] [Related]
11. Non-melanoma skin cancer and ten-year all-cause mortality: a population-based cohort study.
Jensen AØ; Lamberg AL; Jacobsen JB; Braae Olesen A; Sørensen HT
Acta Derm Venereol; 2010 Jul; 90(4):362-7. PubMed ID: 20574600
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark.
Steding-Jessen M; Birch-Johansen F; Jensen A; Schüz J; Kjær SK; Dalton SO
Cancer Epidemiol; 2010 Dec; 34(6):689-95. PubMed ID: 20638927
[TBL] [Abstract][Full Text] [Related]
13. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
14. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
Nguyen AH; Detty SQ; Agrawal DK
Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
18. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
19. Clinical triage of cutaneous squamous cell carcinoma and basal cell carcinoma to avoid treatment delay: value of an electronic booking system.
Fremlin GA; Bray AP; de Berker DA
Clin Exp Dermatol; 2014 Aug; 39(6):689-95. PubMed ID: 25039592
[TBL] [Abstract][Full Text] [Related]
20. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]